Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Tirzepatide for Sale > Buy Tirzepatide 10mg 15mg 30mg 60mg GLP1 Lyophilized powder
Buy Tirzepatide 10mg 15mg 30mg 60mg GLP1 Lyophilized powder buy - large image1
Buy Tirzepatide 10mg 15mg 30mg 60mg GLP1 Lyophilized powder buy - image1
Buy Tirzepatide 10mg 15mg 30mg 60mg GLP1 Lyophilized powder buy - image2
Buy Tirzepatide 10mg 15mg 30mg 60mg GLP1 Lyophilized powder buy - image3
Buy Tirzepatide 10mg 15mg 30mg 60mg GLP1 Lyophilized powder buy - image4
Buy Tirzepatide 10mg 15mg 30mg 60mg GLP1 Lyophilized powder buy - image5
Buy Tirzepatide 10mg 15mg 30mg 60mg GLP1 Lyophilized powder buy - image6

Buy Tirzepatide 10mg 15mg 30mg 60mg GLP1 Lyophilized powder

TDS 134 Inquiries

Unit Price: Get Latest Price
CAS No.:

2023788-19-2

Grade:

Pharmaceutical Grade

Content:

99.98%

Port:

shenzhen

Brand:

no brand

Packaging:

10vials per box

Price valid (until):

2026-07-16

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents
Average Lead Time:
1 days
Qualification:
Main Products:

11

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    GLP-1 Wholesale.


    Semaglutide, Tirzepatide, Retatrutide, NAD, GHK-CU, Melanotan, Polypeptide  
    5mg 10mg 15mg 20mg 30mg 1g
     


    Our Advantages: 
    High purity, Wholesale price, large stock, Stealth Shipping, 100% Delivery Guaranted


    Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1.

    Function:
    1.Diabetes Type 2 Medicine
    2.Oral GLP-1RA Medication
    3.Weight Loss
    4.Diabetes Mellitus
    5.Obesity
    6.Diabetic Coma (in DM Type II)
    7.Diabetic Ketoacidosis (in DM Type II)
    8. Cardiovascular Risk Reduction


    tirzepatide peptide for weight loss

    Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that is being developed for the treatment of type 2 diabetes. Tirzepatide (LY3298176) shows significantly better efficacy with regard to glucose control and weight loss than do Dulaglutide.

    Tirzepatide, also known as LY 3298176, is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Tirzepatide has a greater affinity to GIP receptors than to GLP-1 receptors, and this dual agonist behavior has been shown to produce greater reductions of hyperglycemia compared to a selective GLP-1 receptor agonist. Signaling studies reported that tirzepatide mimics the actions of natural GIP at the GIP receptor. Tirzepatide was approved for improving blood sugar control in adults with type 2 diabetes, as an addition to diet and exercise.


    Shop CAS 2023788-19-2 Tirzepatide Peptide Weight Loss GLP-1-Detailed Image 1 Shop CAS 2023788-19-2 Tirzepatide Peptide Weight Loss GLP-1-Detailed Image 2 Shop CAS 2023788-19-2 Tirzepatide Peptide Weight Loss GLP-1-Detailed Image 3



    Cas No. 2023788-19-2 SDF
    Formula C225H348N48O68 M.Wt 4813.45
    Solubility Soluble in DMSO Storage Store at -20°C
    General tips For obtaining a higher solubility, please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. Stock solution can be stored below -20℃ for several months.
    Shipping Condition Secure

    Appearance: Powder

    Purity: >98% (or refer to the Certificate of Analysis)

    Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

    Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

    Solubility: To be determined

    Shelf Life: >2 years if stored properly

    Drug Formulation: To be determined

    Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

    HS Tariff Code: 2934.99.9001


    99% Raw Finished Powder Peptide Tirze for Weight Loss 10mg 15mg 30mg Vials Manufacture Supply Peptides Tirze for Fat Dissovling Once-Weekly Cagrilintide Sema


    Shop CAS 2023788-19-2 Tirzepatide Peptide Weight Loss GLP-1-Detailed Image 4


    FAQ:


    Is tirzepatide available for weight loss?

    It's also FDA approved for chronic weight management in adults with or without diabetes. Along with diet and exercise, tirzepatide can lead to significant weight loss — an average of 15% to 20% (34 lbs to 48 lbs). But tirzepatide for weight loss is only recommended for people who meet certain BMI criteria


    How fast do you lose weight on tirzepatide?

    How quickly you lose weight depends on factors like lifestyle habits, diet, activity level, age, and other medications you may be taking. However, most people who follow a healthy diet and exercise routine begin reporting some weight loss within a month to two months of starting the medication.


    Is tirzepatide safe to take?

     Tirzepatide, as a weight loss drug, significantly reduces BMI, waist circumference and body weight while gastrointestinal adverse reactions need to be vigilant. Overall, its efficacy is significant and its safety is high.

    Product name Semaglutide/Tirzepatide CAS No. 910463-68-2/2023788-19-2
    Molecular formula C187H291N45O59 Molecular weight 4113.57754
    EINECS No. 203-405-2 Appearance White powder
    Purity 99% Function Weight loss


    Shop CAS 2023788-19-2 Tirzepatide Peptide Weight Loss GLP-1-Detailed Image 5



    Why choose us


    1. All peptides and raws purity >=99% purity
    Many HPLC test reports are available.
    2. 100% Safe delivery
    3. Oversea warehouses and stocks: USA, Canada, Europe and Australia.
    4. Cheapest prices in the market, unbeatable!
    5. Payment options: Credit card, bank transfer, wise, alipay,wechat, bitcoin,usdt,Money gram,WU




    Shop CAS 2023788-19-2 Tirzepatide Peptide Weight Loss GLP-1-Detailed Image 6



    Common Name Tirzepatide
    CAS Number 2023788-19-2 Molecular Weight 4813.45
    Density N/A Boiling Point N/A
    Molecular Formula C225H348N48O68 Melting Point N/A
    MSDS N/A Flash Point N/A
    ECHEMI Editorial Reference

    Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

    Certificates

    Basic Info
    Product Name:

    Tirzepatide

    Other Name:

    LY3298176;

    CAS No.:

    2023788-19-2

    Molecular Formula:

    C225H348N48O68

    Molecular Weight:

    4813

    EC Number:

    200-001-8

    Characteristics
    Appearance:

    White to off-white

    Research
    Class:

    Dual agonist — GIPR, GLP-1R

    Status:

    FDA-approved (Mounjaro / Zepbound)

    Mechanism:

    Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

    EC50 (Human GLP1R):

    0.934 nM

    EC50 (Human GIPR):

    0.0224 nM

    Source:

    Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

    FDA:

    Mounjaro, Zepbound (approved 2022-05-13)

    References
    ChEMBL:

    CHEMBL4297839

    DrugBank:

    DB15171

    KEGG DRUG:

    D11360

    PubChem:

    PubChem

    Disclaimer:

    Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    11

    Location:

    huayin

    Payment Terms:

    TT against copy of documents

    Average lead Time:

    1 days

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    5-10

    Year of Establishment:

    2023

  • Inquiry History
    134 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Trizepatide 2023788-19-2 Raw Material LY3298176 Tirzepatide powder

    1  Dec 2, 2025
    United States

    Tirzepatide

    24 MT Feb 10, 2026
    United States

    Tirzepatide

    1 G Sep 1, 2026
    United States

    Tirzepatide

    50 G Oct 7, 2026
    Brazil

    Tirzepatide

    2.00 G Jun 23, 2026
    United States

    Tirzepitide 30 and 60

    100 MT Jun 14, 2026
    United States

    ISO9001 Tirzepatide 60mg vials x10 freeze dried powder for export

    2 PCS May 3, 2026
    Nigeria

    Tirzepatide

    1000.00 MG Apr 23, 2026
    Costa Rica

    Tirzepatide 20mg 30mg 40mg 50m

    10 MT Apr 8, 2026
    Philippines

    Tirzepatide

    1 G Apr 3, 2026
    United States

    Tirzepatide

    300 MG Dec 28, 2025
    Philippines

    TR15 & TR30

    10 PCS Nov 19, 2025
    United States

    Tirzepatide & Semaglutide

    5000 MG Aug 19, 2025
    United States

    Tirzepatide

    50 MT May 1, 2025
    United States

    Tirzepatide TR15

    10 MG Feb 17, 2025
    Philippines

    Tirzepatide

    10  Jan 21, 2025
    United States

    Tirz or Reta

    10 MT Sep 17, 2024
    United States

    Tirzepatide

    5 MG Jul 5, 2024
    United States

    April Tirzepatide

    10 MG Jun 28, 2024
    United States

    Tirzepatide

    10  Feb 14, 2024
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.